Overview
Li-xiang Wu practices practicing medicine in Changsha, China.
Their clinical expertise encompasses Secondary Parkinsonism, Glioblastoma, Astrocytoma, and Glioma.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Li-xiang Wu
Is Li-xiang Wu a top-rated expert for Secondary Parkinsonism?
MediFind is an objective health platform that identifies experts based on real-world data. Li-xiang Wu is classified as an Experienced expert for Secondary Parkinsonism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Li-xiang Wu participate in research or clinical trials?
Yes. Li-xiang Wu has published 8 articles and abstracts on conditions like Secondary Parkinsonism. You can view a list of Li-xiang Wu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaWu isExperienced. Learn about Astrocytoma.
- GlioblastomaWu isExperienced. Learn about Glioblastoma.
- GliomaWu isExperienced. Learn about Glioma.
- Gliomatosis CerebriWu isExperienced. Learn about Gliomatosis Cerebri.
- Secondary ParkinsonismWu isExperienced. Learn about Secondary Parkinsonism.